Results 151 to 160 of about 3,523 (219)

De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-Infected Tissues: Implications for Primary Letermovir Resistance

, 2019
Horim Jo, Da Eun Kwon, Sang Hoon Han, Seo Yeon Min, Yeon‐Mi Hong, Beom Jin Lim, Kyoung Hwa Lee, Jeong-Hyeon Jo   +7 more
openalex   +2 more sources

Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation. [PDF]

Clin Infect Dis
Heldman MR, Boeckh MJ, Limaye AP.
europepmc   +1 more source

Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians [PDF]

David M. Burger, L. Nijboer, Mira Ghobreyal, Johan Maertens, Nicole M. A. Blijlevens, Luuk B. Hilbrands, Marije C. Baas, Per Ljungman, Roger J. M. Brüggemann   +8 more
openalex   +1 more source

Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study. [PDF]

Antimicrob Agents Chemother
Groll AH, Danziger-Isakov L, Gefen A, Fraser CJ, Schulte JH, Bielorai B, Karras NA, Bueno D, Shaw PJ, Broyde N, Haber B, Gilbert CL, Patel M, McCrea JB, Badshah C.   +14 more
europepmc   +1 more source

New evidence in the management of CMV infection: impact on prophylaxis and treatment. [PDF]

Rev Esp Quimioter
Fortún J.
europepmc   +1 more source

Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R+) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (pts).

, 2019
Sanjeet Dadwal, Monzr M. Al Malki, Dongyun Yang, Bernard Tegtmeier, Justine Abella Ross, Sally Mokhtari, Guido Marcucci, Joycelynne Palmer, Amandeep Salhotra, Jana Dickter, Margaret O’Donnell, Eileen Smith, Chatchada Karanes, David S. Snyder, Matthew Mei, Vinod Pullarkat, Ibrahim Aldoss, Anthony S. Stein, Karamjeet Sandhu, Ricardo Spielberger, Auayporn Nademanee, James I. Ito, Stephen J. Forman, John A. Zaia, Ryotaro Nakamura   +24 more
openalex   +1 more source

Population pharmacokinetic analysis of letermovir in adult hematopoietic cell transplant recipients. [PDF]

Antimicrob Agents Chemother
Royston L, Kunz C, Tonoli D, Lescuyer P, Neofytos D, Gotta V.   +5 more
europepmc   +1 more source

Evaluating the relationship between letermovir prophylaxis and medication regimen complexity Index over time in allogeneic hematopoietic stem cell transplant patients

Anthony Quach, Nimish Patel, Hailey Hirata, Annie Bui, Julie Trinh, Shashi Bahl, Ila M. Saunders   +6 more
openalex   +1 more source

Letermovir for Secondary Prophylaxis in Resistant CMV in Pediatric Heart Transplant Recipients: A Single Center Experience [PDF]

J. Coppola, Debbie‐Ann Shirley, Vincent Probst, Heather Blanchette, E. Martin, J. Rackley, Andrew Ramsey, Eugene Piazza, Biagio A. Pietra, Dipankar Gupta   +9 more
openalex   +1 more source

Letermovir use may impact on the Cytomegalovirus DNA fragmentation profile in plasma from allogeneic hematopoietic stem cell transplant recipients [PDF]

Estela Giménez, Roberto Gozalbo‐Rovira, Eliseo Albert, José Luís Piñana, Carlos Solano, David Navarro   +5 more
openalex   +1 more source